ATS 2018 International Conference - Mobile

OATD-01, a Dual Chitinase Inhibitor, Significantly Ameliorates Pulmonary Fibrosis in the Bleomycin-Induced Mouse Model [Board No. 906]

Location: Board no. 906

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Monday

May

21

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Katarzyna Gorska

MD, PhD
Medical University of Warsaw

Patrycja Nejman-Gryz

PhD
Medical University of Warsaw

Pawel Dobrzanski

PhD
OncoArendi Therapeutics SA

Marta Maskey-Warzechowska

MD, PhD
Medical University of Warsaw

Adam Golebiowski

PhD
OncoArendi Therapeutics SA

Barbara Dymek

MSc
OncoArendi Therapeutics SA

Robert Koralewski

MSc
OncoArendi Therapeutics SA

Karolina Dzwonek

PhD
OncoArendi Therapeutics SA

Piotr Sklepkiewicz

PhD
OncoArendi Therapeutics SA

Michal Mlacki

PhD
OncoArendi Therapeutics SA

Marzena Mazur

MSc
OncoArendi Therapeutics SA

Malgorzata Proboszcz

MSc
Medical University of Warsaw

Rafal Krenke

MD, PhD, Prof.
Medical University of Warsaw

Magdalena Paplinska-Goryca

PhD
Medical University of Warsaw

Natalia Przysucha

MD
Medical University of Warsaw

Agnieszka Zagozdzon

MSc
OncoArendi Therapeutics SA

View Abstract

OATD-01, a Dual Chitinase Inhibitor, Significantly Ameliorates Pulmonary Fibrosis in the Bleomycin-Induced Mouse Model

Parent Sessions

B107 - MECHANISTIC ADVANCES IN PULMONARY FIBROSIS...
05-21-2018 2:15 PM - 4:15 PM